Cellular nucleophilic sulfur-containing sites

Cellular nucleophilic sulfur-containing sites primarily consist of the sulfhydryl (-SH) groups found in the tripeptide glutathione (GSH) and the amino acid cysteine within proteins (Source: PubChem, CID 124886). These sites serve as critical defense mechanisms by acting as sacrificial targets for reactive electrophilic species, including drug metabolites and environmental toxins (Source: StatPearls, NBK441917). In a physiological context, they maintain cellular redox homeostasis and protect vital macromolecules from oxidative damage. Many therapeutic agents, particularly alkylating antineoplastics like busulfan or platinum-based drugs like cisplatin, interact with these sites through covalent bonding (Source: PubMed, PMID 11512925). Conversely, the depletion of these nucleophilic sites, such as during acetaminophen overdose, leads to the accumulation of toxic metabolites like NAPQI, resulting in severe hepatotoxicity (Source: NIH, LiverTox). Therapeutic strategies often involve replenishing these sites using precursors like N-acetylcysteine to restore the cell's antioxidant capacity (Source: PubMed, PMID 24835152). Because these sites are ubiquitous and non-specific, they are often associated with off-target drug effects and systemic toxicity.

Other names

Sulfhydryl groupsThiolsNucleophilic sulfurProtein thiolsGlutathione

Electrophilic drugs or metabolites form covalent adducts with nucleophilic sulfur atoms in glutathione or protein cysteine residues, leading to detoxification or cellular damage (Source: PubMed, PMID 15451381).